+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Oxidized Regenerated Cellulose Based Hemostats Market by Product Type (Film, Foam, Gauze), Sales Channel (Offline, Online Sales), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5460319
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The oxidized regenerated cellulose based hemostats market is experiencing strong momentum, driven by shifts in surgical practice, evolving clinical requirements, and increased focus on operational efficiencies. Senior leaders in medical device procurement, manufacturing, and hospital operations are seeking reliable market intelligence to inform investment, supply chain resilience, and portfolio management strategies.

Market Snapshot: Growth of the Oxidized Regenerated Cellulose Based Hemostats Market

The oxidized regenerated cellulose based hemostats market grew from USD 205.07 million in 2024 to USD 231.00 million in 2025. It is expected to continue expanding at a CAGR of 12.42%, reaching USD 413.97 million by 2030. This market expansion reflects rising adoption in operating suites globally, sustained innovation in absorbable hemostatic matrices, and widening procedural applications.

Scope & Segmentation: Strategic Overview and Market Structure

This research delivers a comprehensive, actionable segmentation across products, channels, medical applications, end users, regions, and key industry players. A focused approach to technological developments and regulatory updates is included.

  • Product Types: Film, Foam, Gauze, Powder
  • Sales Channels: Offline, Online (ecommerce platforms, manufacturer websites)
  • Applications: Cardiovascular (bypass, valve replacement), Dental (implant, oral surgery), ENT (sinus surgery, tonsillectomy), General Surgery (minimally invasive, open), Gynecological (hysterectomy, myomectomy), Orthopedic (joint, spine, trauma), Urology (cystectomy, nephrectomy)
  • End Users: Ambulatory surgical centers (multi- and single-specialty), Clinics (daycare, outpatient), Hospitals (secondary, tertiary)
  • Geographies: Americas (with coverage of the US, Canada, Mexico, Brazil, Argentina), Europe, Middle East, and Africa (including UK, Germany, France, Italy, and others), Asia-Pacific (China, India, Japan, Australia, Indonesia, and additional markets)
  • Key Companies: Johnson & Johnson, Medtronic plc, Baxter International Inc., 3M Company, B. Braun Melsungen AG, Becton, Dickinson and Company, Stryker Corporation, Teleflex Incorporated, Integra LifeSciences Holdings Corporation, CryoLife, Inc.

Key Takeaways for Senior Decision-Makers

  • Adoption of oxidized regenerated cellulose hemostatic solutions is accelerating in both high-volume and specialty surgery centers, reflecting their adaptability and compatibility with minimally invasive and open procedures.
  • Manufacturers are investing in advanced composite technologies and antimicrobial features to differentiate products for infection control and procedural efficiency.
  • Growth in digital sales platforms is enabling broader access, allowing smaller clinics and outpatient centers to source these critical hemostatic agents with improved lead times and transactional transparency.
  • Strategic collaborations between medical device firms and surgical instrument manufacturers are facilitating integrated delivery systems and procedural workflow enhancements.
  • Sustainability initiatives and local production capabilities are emerging as decision factors in procurement, particularly under shifting regulatory and market dynamics in global regions.

Tariff Impact and Supply Chain Adaptation

Recent U.S. tariffs on cellulose derivatives and hemostatic matrices have altered supply chain considerations, pushing manufacturers to expand North American capacity and invest in automation. These changes require stakeholders to reassess vendor relationships, regional sourcing, and inventory strategies to maintain cost and supply stability in critical care environments.

Methodology & Data Sources

This report combines rigorous primary research, including structured interviews with surgeons, procurement decision-makers, and regulatory experts, with secondary research from regulatory databases, clinical journals, and company disclosures. Multi-stage validation procedures and comparative scenario analyses ensure reliability and applicability for strategic planning in the oxidized regenerated cellulose based hemostats market.

Why This Report Matters for B2B Decision-Makers

  • Offers a structured, independent assessment of supply, demand, technology, and regulation for targeted roadmap and investment decisions.
  • Enables risk mitigation through supply chain intelligence and actionable insights on emerging procurement channels and sustainability pressures.
  • Supports commercial strategy by identifying emerging procedural demand drivers and regional opportunities for differentiated positioning and partnership.

Conclusion

The oxidized regenerated cellulose based hemostats market is undergoing rapid transformation shaped by innovation, regulatory changes, and evolving clinical standards. Leaders who leverage actionable intelligence and respond with agility will be better positioned to address dynamic patient, hospital, and healthcare system priorities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of antimicrobial agents into oxidized regenerated cellulose to reduce surgical site infections
5.2. Adoption of oxidized regenerated cellulose hemostats in robotic and minimally invasive surgeries for precise bleeding control
5.3. Development of sprayable and foam formulations of oxidized regenerated cellulose for noncontact wound hemostasis
5.4. Surge in Asia-Pacific regulatory approvals accelerating market availability of cellulose based hemostatic products
5.5. Collaborations between biomaterial innovators and surgical device manufacturers to enhance hemostat performance
5.6. Advancements in ecofriendly production methods for oxidized regenerated cellulose to meet sustainability goals
5.7. Clinical studies demonstrating improved outcomes in neurosurgical bleeding management with cellulose hemostats
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Oxidized Regenerated Cellulose Based Hemostats Market, by Product Type
8.1. Introduction
8.2. Film
8.3. Foam
8.4. Gauze
8.5. Powder
9. Oxidized Regenerated Cellulose Based Hemostats Market, by Sales Channel
9.1. Introduction
9.2. Offline
9.3. Online Sales
9.3.1. Ecommerce Platform
9.3.2. Manufacturer Website
10. Oxidized Regenerated Cellulose Based Hemostats Market, by Application
10.1. Introduction
10.2. Cardiovascular
10.2.1. Bypass Surgery
10.2.2. Valve Replacement
10.3. Dental
10.3.1. Implant Surgery
10.3.2. Oral Surgery
10.4. Ent
10.4.1. Sinus Surgery
10.4.2. Tonsillectomy
10.5. General Surgery
10.5.1. Minimally Invasive
10.5.2. Open Surgery
10.6. Gynecological
10.6.1. Hysterectomy
10.6.2. Myomectomy
10.7. Orthopedic
10.7.1. Joint Replacement
10.7.2. Spine Surgery
10.7.3. Trauma Surgery
10.8. Urology
10.8.1. Cystectomy
10.8.2. Nephrectomy
11. Oxidized Regenerated Cellulose Based Hemostats Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Center
11.2.1. Multi Specialty Center
11.2.2. Single Specialty Center
11.3. Clinic
11.3.1. Daycare Clinic
11.3.2. Outpatient Clinic
11.4. Hospital
11.4.1. Secondary Hospital
11.4.2. Tertiary Hospital
12. Americas Oxidized Regenerated Cellulose Based Hemostats Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Oxidized Regenerated Cellulose Based Hemostats Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Oxidized Regenerated Cellulose Based Hemostats Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Johnson & Johnson
15.3.2. Medtronic plc
15.3.3. Baxter International Inc.
15.3.4. 3M Company
15.3.5. B. Braun Melsungen AG
15.3.6. Becton, Dickinson and Company
15.3.7. Stryker Corporation
15.3.8. Teleflex Incorporated
15.3.9. Integra LifeSciences Holdings Corporation
15.3.10. CryoLife, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET: RESEARCHAI
FIGURE 24. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET: RESEARCHSTATISTICS
FIGURE 25. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET: RESEARCHCONTACTS
FIGURE 26. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY FILM, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY FILM, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY FOAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY FOAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GAUZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GAUZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ECOMMERCE PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ECOMMERCE PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY BYPASS SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY BYPASS SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY VALVE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY VALVE REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DENTAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DENTAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY IMPLANT SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY IMPLANT SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ORAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ORAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DENTAL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SINUS SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SINUS SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY TONSILLECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY TONSILLECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ENT, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ENT, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY OPEN SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY HYSTERECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY HYSTERECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY MYOMECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY MYOMECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SPINE SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SPINE SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY TRAUMA SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY TRAUMA SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY UROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY UROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CYSTECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CYSTECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY NEPHRECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY NEPHRECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY UROLOGY, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY UROLOGY, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY MULTI SPECIALTY CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY MULTI SPECIALTY CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SINGLE SPECIALTY CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SINGLE SPECIALTY CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DAYCARE CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DAYCARE CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY OUTPATIENT CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SECONDARY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SECONDARY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY TERTIARY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY TERTIARY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DENTAL, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ENT, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ENT, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY UROLOGY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY UROLOGY, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DENTAL, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ENT, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ENT, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY UROLOGY, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY UROLOGY, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 181. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 186. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 187. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 190. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 191. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
TABLE 192. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DENTAL, 2025-2030 (USD MILLION)
TABLE 193. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ENT, 2018-2024 (USD MILLION)
TABLE 194. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ENT, 2025-2030 (USD MILLION)
TABLE 195. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 196. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 197. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL, 2018-2024 (USD MILLION)
TABLE 198. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL, 2025-2030 (USD MILLION)
TABLE 199. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
TABLE 200. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
TABLE 201. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY UROLOGY, 2018-2024 (USD MILLION)
TABLE 202. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY UROLOGY, 2025-2030 (USD MILLION)
TABLE 203. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
TABLE 206. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2030 (USD MILLION)
TABLE 207. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 208. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 209. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 210. CANADA OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 211. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 216. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 217. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 220. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 221. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
TABLE 222. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DENTAL, 2025-2030 (USD MILLION)
TABLE 223. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ENT, 2018-2024 (USD MILLION)
TABLE 224. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ENT, 2025-2030 (USD MILLION)
TABLE 225. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 226. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 227. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL, 2018-2024 (USD MILLION)
TABLE 228. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL, 2025-2030 (USD MILLION)
TABLE 229. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
TABLE 230. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
TABLE 231. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY UROLOGY, 2018-2024 (USD MILLION)
TABLE 232. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY UROLOGY, 2025-2030 (USD MILLION)
TABLE 233. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
TABLE 236. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2030 (USD MILLION)
TABLE 237. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 238. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 239. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 240. MEXICO OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY DENTAL, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ENT, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ENT, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GENERAL SURGERY, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY GYNECOLOGICAL, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY ORTHOPEDIC, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY UROLOGY, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY UROLOGY, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CLINIC, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY CLINIC, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL OX

Samples

Loading
LOADING...

Companies Mentioned

  • Johnson & Johnson
  • Medtronic plc
  • Baxter International Inc.
  • 3M Company
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Stryker Corporation
  • Teleflex Incorporated
  • Integra LifeSciences Holdings Corporation
  • CryoLife, Inc.

Table Information